Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by Dynamic Technology Lab Private Ltd

Dynamic Technology Lab Private Ltd lowered its holdings in Teladoc Health, Inc. (NYSE:TDOC) by 40.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 27,157 shares of the health services provider’s stock after selling 18,184 shares during the period. Dynamic Technology Lab Private Ltd’s holdings in Teladoc Health were worth $585,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in the business. M&T Bank Corp grew its position in Teladoc Health by 5.5% in the fourth quarter. M&T Bank Corp now owns 11,152 shares of the health services provider’s stock valued at $241,000 after acquiring an additional 584 shares in the last quarter. Van ECK Associates Corp increased its stake in Teladoc Health by 20.3% during the 4th quarter. Van ECK Associates Corp now owns 3,589 shares of the health services provider’s stock worth $77,000 after buying an additional 606 shares during the period. Arizona State Retirement System increased its stake in Teladoc Health by 1.4% during the 3rd quarter. Arizona State Retirement System now owns 46,602 shares of the health services provider’s stock worth $866,000 after buying an additional 650 shares during the period. Victory Capital Management Inc. lifted its holdings in Teladoc Health by 4.3% in the 3rd quarter. Victory Capital Management Inc. now owns 17,946 shares of the health services provider’s stock worth $334,000 after buying an additional 748 shares in the last quarter. Finally, Principal Financial Group Inc. boosted its position in Teladoc Health by 7.4% in the 3rd quarter. Principal Financial Group Inc. now owns 12,774 shares of the health services provider’s stock valued at $237,000 after buying an additional 883 shares during the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Teladoc Health Trading Down 4.0 %

NYSE:TDOC opened at $11.45 on Friday. The company has a market capitalization of $1.94 billion, a P/E ratio of -8.12 and a beta of 0.97. The stock’s 50 day moving average price is $13.66 and its 200 day moving average price is $17.04. The company has a debt-to-equity ratio of 0.67, a quick ratio of 3.74 and a current ratio of 3.82. Teladoc Health, Inc. has a 52 week low of $11.40 and a 52 week high of $30.41.

Teladoc Health (NYSE:TDOC) last posted its earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.47) by ($0.02). Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. The company had revenue of $646.13 million during the quarter, compared to analyst estimates of $637.31 million. During the same quarter last year, the firm posted ($0.37) earnings per share. The firm’s revenue for the quarter was up 2.7% compared to the same quarter last year. On average, research analysts forecast that Teladoc Health, Inc. will post -1.05 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CTO Nikolaos P. Nanis sold 2,866 shares of the stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $14.52, for a total value of $41,614.32. Following the completion of the transaction, the chief technology officer now directly owns 69,850 shares of the company’s stock, valued at approximately $1,014,222. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other Teladoc Health news, COO Michael Willem Waters sold 5,793 shares of the company’s stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total transaction of $73,513.17. Following the transaction, the chief operating officer now owns 64,881 shares of the company’s stock, valued at approximately $823,339.89. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CTO Nikolaos P. Nanis sold 2,866 shares of the company’s stock in a transaction on Monday, March 4th. The shares were sold at an average price of $14.52, for a total value of $41,614.32. Following the transaction, the chief technology officer now directly owns 69,850 shares in the company, valued at approximately $1,014,222. The disclosure for this sale can be found here. In the last quarter, insiders sold 137,368 shares of company stock worth $1,968,587. 0.95% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of brokerages have recently issued reports on TDOC. Piper Sandler cut their target price on shares of Teladoc Health from $30.00 to $25.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 21st. SVB Leerink started coverage on Teladoc Health in a research report on Monday, February 26th. They set a “market perform” rating and a $17.00 price target on the stock. JPMorgan Chase & Co. decreased their price objective on shares of Teladoc Health from $19.00 to $16.00 and set a “neutral” rating for the company in a report on Tuesday. Truist Financial dropped their target price on shares of Teladoc Health from $23.00 to $17.00 and set a “hold” rating on the stock in a report on Wednesday, March 6th. Finally, DA Davidson lowered their price objective on shares of Teladoc Health from $22.00 to $18.00 and set a “neutral” rating for the company in a research report on Wednesday, February 21st. Thirteen equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Teladoc Health currently has an average rating of “Hold” and an average price target of $18.22.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.